These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 12941762

  • 1. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes.
    Valverde AM, Burks DJ, Fabregat I, Fisher TL, Carretero J, White MF, Benito M.
    Diabetes; 2003 Sep; 52(9):2239-48. PubMed ID: 12941762
    [Abstract] [Full Text] [Related]

  • 2. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes.
    Valverde AM, Fabregat I, Burks DJ, White MF, Benito M.
    Hepatology; 2004 Dec; 40(6):1285-94. PubMed ID: 15565601
    [Abstract] [Full Text] [Related]

  • 3. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A, Clampit JE, Escribano O, Benito M, Rondinone CM, Valverde AM.
    Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, Kobayashi M.
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [Abstract] [Full Text] [Related]

  • 5. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes.
    Matsumoto M, Ogawa W, Teshigawara K, Inoue H, Miyake K, Sakaue H, Kasuga M.
    Diabetes; 2002 Jun; 51(6):1672-80. PubMed ID: 12031952
    [Abstract] [Full Text] [Related]

  • 6. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C, Arribas M, Benito M, Valverde AM.
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.
    Taniguchi CM, Ueki K, Kahn R.
    J Clin Invest; 2005 Mar; 115(3):718-27. PubMed ID: 15711641
    [Abstract] [Full Text] [Related]

  • 13. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart.
    Laviola L, Belsanti G, Davalli AM, Napoli R, Perrini S, Weir GC, Giorgino R, Giorgino F.
    Diabetes; 2001 Dec; 50(12):2709-20. PubMed ID: 11723053
    [Abstract] [Full Text] [Related]

  • 14. Insulin-induced up-regulated uncoupling protein-1 expression is mediated by insulin receptor substrate 1 through the phosphatidylinositol 3-kinase/Akt signaling pathway in fetal brown adipocytes.
    Valverde AM, Arribas M, Mur C, Navarro P, Pons S, Cassard-Doulcier AM, Kahn CR, Benito M.
    J Biol Chem; 2003 Mar 21; 278(12):10221-31. PubMed ID: 12525499
    [Abstract] [Full Text] [Related]

  • 15. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism.
    Miele C, Riboulet A, Maitan MA, Oriente F, Romano C, Formisano P, Giudicelli J, Beguinot F, Van Obberghen E.
    J Biol Chem; 2003 Nov 28; 278(48):47376-87. PubMed ID: 12970360
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes.
    Takano A, Haruta T, Iwata M, Usui I, Uno T, Kawahara J, Ueno E, Sasaoka T, Kobayashi M.
    Diabetes; 2001 Aug 28; 50(8):1891-900. PubMed ID: 11473053
    [Abstract] [Full Text] [Related]

  • 17. Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance.
    Pagliassotti MJ, Kang J, Thresher JS, Sung CK, Bizeau ME.
    Am J Physiol Endocrinol Metab; 2002 Jan 28; 282(1):E170-6. PubMed ID: 11739098
    [Abstract] [Full Text] [Related]

  • 18. Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells.
    D'Alessandris C, Andreozzi F, Federici M, Cardellini M, Brunetti A, Ranalli M, Del Guerra S, Lauro D, Del Prato S, Marchetti P, Lauro R, Sesti G.
    FASEB J; 2004 Jun 28; 18(9):959-61. PubMed ID: 15059979
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
    Lochhead PA, Coghlan M, Rice SQ, Sutherland C.
    Diabetes; 2001 May 28; 50(5):937-46. PubMed ID: 11334436
    [Abstract] [Full Text] [Related]

  • 20. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T, Hori H, Wada T, Ishiki M, Haruta T, Ishihara H, Kobayashi M.
    Diabetologia; 2001 Oct 28; 44(10):1258-67. PubMed ID: 11692174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.